next »

[dudette]

On 28th November 2008, we recommended to Buy "Suven Life Sciences Ltd" @ Rs.34.80 and after our recommendation, it has reached the highest  Rs.64.45  (More than 85 % return with in 5 weeks). Due to the recent market crash, this scrip valuation is now at very attractive price.

 
Now read the latest news about Suven Life Sciences Ltd:-

 
Suven Life Sciences has entered into an agreement with Eli Lilly to collaborate on the pre-clinical research of molecules in the therapeutic area of central nervous system disorders.
 

As per the agreement, Suven will be responsible for discovery activities related to the identification and selection of clinical candidates in the area of central nervous system disorders, in close association with Eli Lilly, US based global pharmaceutical company.

 
Suven will receive research funding and as well as potential discovery and development milestone payments in the range of $19 million to $23 million per candidate and potential royalties on net sales of any products that may be successfully commercialised from the collaboration.
 

At current market price, we are advising investors to "HOLD & ACCUMULATE" this scrip for long term.